Scarica l'app Stockscreener
2.99
6.85%
-0.22
Dopo l'orario di chiusura:
2.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.21
Aprire:
$3.4
Volume 24 ore:
98,971
Relative Volume:
2.31
Capitalizzazione di mercato:
$44.73M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-4.0959
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
-14.33%
1M Prestazione:
-4.17%
6M Prestazione:
-38.10%
1 anno Prestazione:
+166.96%
Intervallo 1D:
$2.96
$3.40
Intervallo di 1 settimana:
$2.96
$3.53
Portata 52W:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
2525 WEST END AVENUE, NASHVILLE,, TN
Confronta CPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
2.99 | 48.02M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Regression analysis insights on Cumberland Pharmaceuticals Inc. performanceMarket Growth Summary & Stock Portfolio Risk Management - newser.com
Heatmap analysis for Cumberland Pharmaceuticals Inc. and competitorsStop Loss & High Accuracy Trade Signal Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery playOil Prices & AI Driven Price Forecasts - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levels2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com
Cumberland Pharmaceuticals Inc. stock outlook for YEAREarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
How to forecast Cumberland Pharmaceuticals Inc. trends using time seriesJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceWall Street Watch & Weekly Top Stock Performers List - newser.com
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidance2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Can Cumberland Pharmaceuticals Inc. stock sustain institutional interestJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Cumberland Pharmaceuticals (Nasdaq: CPIX) to Report Q3 2025 Results, Hosting Investor Call - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock maintain growth storyEarnings Trend Report & Accurate Intraday Trade Tips - Fundação Cultural do Pará
How moving averages guide Cumberland Pharmaceuticals Inc. tradingJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
What insider trading reveals about Cumberland Pharmaceuticals Inc. stockWeekly Investment Summary & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Published on: 2025-10-27 22:22:34 - newser.com
Cumberland Pharmaceuticals’ Promising Phase II Study on Ifetroban for IPF - TipRanks
Will Cumberland Pharmaceuticals Inc. stock rally after Fed decisionsWeekly Loss Report & Verified Trade Idea Suggestions - Fundação Cultural do Pará
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.18%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):